It has been reported that overexpression of HtrA1 in several cancers could suppress cell growth, migration, and invasion, while HtrA1 knockdown in cancers induces resistance to conventional chemotherapeutics (10,12,22–24). This evidence concerns the gene HTRA1 and cancer.